Sanity 2.0s System

Sanity 2.0s System

Lab Automation System

Information

Based on the principle of real-time PCR detection, Sanity 2.0s System is designed to be used with dedicated testing reagents for the clinical qualitative detection of target nucleic acids (DNA/RNA) from human samples, including pathogens and human genes. The Sanity 2.0s System is an all-in-one molecular diagnostic platform designed for the detection of infectious diseases. It streamlines the process, covering nucleic acid extraction, real-time PCR preparation and detection, as well as data analysis. The operation is straightforward, with manual steps that take less than 5 minutes to complete. This system is engineered for efficiency and ease of use, minimizing the time and effort required for the user while maintaining the accuracy and reliability of molecular diagnostics. A wide range of diagnostic tests can be run on Sanity 2.0s System, including tuberculosis (TB/MDR), NTM, respiratory pathogen panels (RPP), HPV, STI, etc.
Xiamen Zeesan Biotech Co., Ltd.H2.F03Established in 2010, Zeesan Biotech has dedicated its expertise to streamlining every step of the diagnostic process, from sample collection, nucleic acid extraction to detection and data analysis. At the heart of Zeesan Biotech's success lies its innovative MMCA and MeltArray technology, which is protected by a robust patent portfolio. This proprietary technology has enabled the development of unique multiplex nucleic acid detection platforms, catering to a diverse array of applications. Zeesan Biotech's TB/NTM solutions are at the forefront of molecular diagnostics, addressing the critical need for accurate and efficient detection of tuberculosis (TB) and its drug-resistant strains, as well as the identification of non-tuberculous mycobacteria (NTM). It is currently one of the most comprehensive solutions for drug-resistant TB testing on the market. By offering this comprehensive suite of integrated services, Zeesan Biotech has positioned itself as a trusted partner for healthcare providers, research institutions, and diagnostic laboratories worldwide. Zeesan Biotech's TB/NTM solutions are currently being utilized in nearly 600 leading medical institutions across China, as well as in over dozens of countries, including India, Indonesia, Thailand, Malaysia, Iran, Pakistan, South Africa, and the United Arab Emirates.

Log in

See all the content and easy-to-use features by logging in or registering!